CBLL Share Price Performance
US$11.80
-13.20 (-52.80%)
Price US$11.80
Share PriceUS$11.80
CeriBell, Inc. (NASDAQ:CBLL) Second-Quarter Results Just Came Out: Here's What Analysts Are Forecasting For This Year
Aug 08
CeriBell, Inc. Stock Price
- 0 Narratives written by author
- 0 Comments on narratives written by author
- 4 Fair Values set on narratives written by author
CBLL Community Narratives
There are no narratives available yet.
CeriBell, Inc. Key Details
Last Reported Earnings
Jun 30, 2025
Next Reporting Earnings
n/a
- Earnings per share (EPS)
- -1.35
- Gross Margin
- 87.75%
- Net Profit Margin
- -63.83%
- Debt/Equity Ratio
- 11.4%
CeriBell, Inc. Competitors
Snowflake Analysis
About CBLL
- Founded
- 2014
- Employees
- 281
- CEO
- WebsiteView website
CeriBell, Inc. operates as a medical technology company focuses on transforming the diagnosis and management of patients with serious neurological conditions in the United States. The company develops Ceribell System, a novel and point-of-care electroencephalography (EEG) platform to address the unmet needs of patients in the acute care setting. It also offers disposable headbands consists of ten non-invasive electrodes pre-filled with conductive gel; and pocket-sized battery-operated recorders to record and store EEG signals generated by the headband. In addition, the company provides Clarity, an AI-powered seizure detection algorithm. Further, it operates Ceribell EEG portal, a cloud-based secured portal that enables real-time remote access to a patient’s EEG data. The company was formerly known as Brain Stethoscope, Inc. and changed its name to CeriBell, Inc. in August 2015. CeriBell, Inc. was incorporated in 2014 and is headquartered in Sunnyvale, California.
Market Insight
Rare earths may be a sliver of the global metals market, but they punch far above their weight. These obscure elements are the invisible wiring of modern life.
Continue reading
U.S. Market Performance
- 7 Days: 0.4%
- 3 Months: 7.8%
- 1 Year: 17.8%
- Year to Date: 14.7%
Over the last 7 days, the market has remained flat, although notably the Healthcare sector gained 3.7% in that time. Meanwhile, the market is actually up 18% over the past year. As for the next few years, earnings are expected to grow by 15% per annum. Market details ›